Committee for Medicinal Products for Human Use (CHMP) | PharmaBharat Tools

Loading term…

About Us Contact Us Disclaimer Privacy Policy Terms and Conditions

© 2026 PharmaBharat. All rights reserved.

Committee for Medicinal Products for Human Use (CHMP) | PharmaBharat Tools

Categories

Advertising, Promotion & Medical Information(7)

Biologics, Biosimilars & ATMPs(9)

Clinical Trial Regulations(32)

Combination Products & Devices(5)

eCTD & Publishing(19)

EU Procedures & Committees(19)

Committee for Advanced Therapies(CAT)Centralised Procedure Committee for Medicinal Products for Human Use(CHMP)Coordination Group for Mutual Recognition and Decentralised Procedures (Human)(CMDh)Concerned Member State(CMS)Co-Rapporteur Committee for Orphan Medicinal Products(COMP)Decentralised Procedure(DCP)European Commission Decision European Public Assessment Report(EPAR)Marketing Authorisation Holder(MAH)Mutual Recognition Procedure(MRP)National Competent Authority(NCA)Paediatric Committee(PDCO)Paediatric Investigation Plan(PIP)Pharmacovigilance Risk Assessment Committee(PRAC)Rapporteur Referral Procedure Reference Member State(RMS)

Expedited & Special Programs(11)

FDA Meetings & Communication(7)

Global Guidance & Harmonisation(5)

ICH Guidelines (E/Q/M Series)(61)

Compliance & Inspections(11)

Post-Approval(25)

Regulatory Strategy & Planning(10)

Regulatory Submissions(25)

User Fees, Timelines & Review(17)

Variations & Amendments(8)

Progress

0%

RA EU Procedures & CommitteesCommittee for Medicinal Products for Human Use

Loading term…

Centralised Procedure Coordination Group for Mutual Recognition and Decentralised Procedures (Human) (CMDh)

Committee for Medicinal Products for Human Use(CHMP)

EU Procedures & Committees

Definition

EMA committee responsible for preparing opinions on questions concerning medicines for human use, including assessment of marketing authorisation applications under the centralised procedure.

Regulatory source

EMA committees overview; Regulation (EC) 726/2004